Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Perrin

Showing results (521-530 of 526) with videos related to

Pageof 53
Sort By:
You have reached the last page of results.This site can display upto 526 results.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J Bateman, Yan Li, Eric M McDade, et al.
Nature Medicine|June 22, 2021
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseStephen Salloway, Martin Farlow, Eric McDade, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU TrialRandall J Bateman, Yan Li, Eric M McDade, et al.
Acta Neuropathologica|November 1, 2021
Genome-wide association study and functional validation implicates JADE1 in tauopathyKurt Farrell, SoongHo Kim, Natalia Han, et al.
JAMA Psychiatry|January 22, 2025
Depressive Symptoms and Amyloid PathologyWietse A Wiels, Julie E Oomens, Sebastiaan Engelborghs, et al.
Nature|June 6, 2020
Identification of type 2 diabetes loci in 433,540 East Asian individualsCassandra N Spracklen, Momoko Horikoshi, Young Jin Kim, et al.
Pageof 53

Showing results (521-530 of 526) with videos related to

Sort By:
Pageof 53
You have reached the last page of results.This site can display upto 526 results.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J Bateman, Yan Li, Eric M McDade, et al.
Nature Medicine|June 22, 2021
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseStephen Salloway, Martin Farlow, Eric McDade, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU TrialRandall J Bateman, Yan Li, Eric M McDade, et al.
Acta Neuropathologica|November 1, 2021
Genome-wide association study and functional validation implicates JADE1 in tauopathyKurt Farrell, SoongHo Kim, Natalia Han, et al.
JAMA Psychiatry|January 22, 2025
Depressive Symptoms and Amyloid PathologyWietse A Wiels, Julie E Oomens, Sebastiaan Engelborghs, et al.
Nature|June 6, 2020
Identification of type 2 diabetes loci in 433,540 East Asian individualsCassandra N Spracklen, Momoko Horikoshi, Young Jin Kim, et al.
Pageof 53